In prostate cancer cells, miR-155 was capable of upregulating annexin 7, which is a substrate of a variant of kinases including protein kinase C involved in cell growth, proliferation, apoptosis and migration [10]. The gene discussed is ANXA7; the disease is prostate carcinoma.